Skip to content
by Legal Desire
6 December 2023

Latham & Watkins Advises Laminar, Inc. in US$400 Million Acquisition by Johnson & Johnson Medtech

Advising firms

Deal team

23 lawyers named
LawyerFirmSeniorityPracticeOffice
Hans Brigham Lead Latham & Watkins LLP Partner corporate Boston
Evan Smith Lead Latham & Watkins LLP Partner corporate Boston
Stefanie Vincent Latham & Watkins LLP Counsel corporate Not stated
Michael Casagrande Latham & Watkins LLP Associate corporate Not stated
Jake Hummer Latham & Watkins LLP Associate corporate Not stated
Galina Vujovic Latham & Watkins LLP Associate corporate Not stated
Sarah Gagan Latham & Watkins LLP Partner IP Boston
Arun Mohan Latham & Watkins LLP Associate IP Not stated
Heather Deixler Latham & Watkins LLP Partner data privacy Bay Area
Mitch Bennett Latham & Watkins LLP Associate data privacy Not stated
Grace Lee Latham & Watkins LLP Partner tax Bay Area
Derek Gumm Latham & Watkins LLP Associate tax Not stated
Josh Friedman Latham & Watkins LLP Partner benefits Boston
Alisa Hand Latham & Watkins LLP Associate benefits Not stated
Laura Waller Latham & Watkins LLP Associate employment Chicago
Betty Pang Latham & Watkins LLP Partner healthcare regulatory Bay Area
John Manthei Latham & Watkins LLP Partner FDA regulatory Washington, D.C.
Chad Jennings Latham & Watkins LLP Counsel FDA regulatory Not stated
Seth Olson Latham & Watkins LLP Associate FDA regulatory Not stated
Mandy Reeves Latham & Watkins LLP Partner antitrust Washington, D.C.
Josh Holian Latham & Watkins LLP Partner antitrust Bay Area
Héctor Armengod Latham & Watkins LLP Partner antitrust Brussels
Patrick English Latham & Watkins LLP Counsel antitrust Washington, D.C.

Stated terms

Stated value
USD 400m (US$400 million)
What the figure measures
Total transaction value
Client
Laminar, Inc.Sell-side
Counterparties
Johnson & Johnson Medtech (Buy-side)